Hello Avatar! Welcome to the BowtiedBiotech podcast, where science meets business! If you're fascinated by breakthrough biotech, bold innovations, and the business behind the science, you're in the right place. Each week, we dive into the world of biotech with fresh insights, sharp analysis, and the stories that are shaping the future of health. Whether you’re an industry insider, an investor, or just biotech-curious, we’ve got something for you.
We are now publishing 7x per week according to the following cadence:
Mondays: BioBucks: Stock Analysis & Biotech Catalysts
Tuesdays: X-article on biotech hot topics
Wednesdays: Podcast format of X-article
Thursdays: Insiders Track: Public & Private Biotech Markets
Fridays: Sweat Equity: Your Weekly Biotech Fix
Saturdays: Podcast format of Weekly News Update
Sundays: Building Biotech: Strategic Topics
SUBSCRIBE TO PODCAST HERE:
Please help spread the work by subscribing and hitting the share button if you are enjoying content!
AI in drug discovery has been one of the hottest topics in biotech this year, and for good reason. Just a year ago, people were skeptical. Large language models—those AIs we hear so much about—had big limitations. They could ‘hallucinate,’ produce unreliable results, and struggled with the complexity of scientific data. The potential was clear, but the reality hadn’t quite caught up. Fast forward to today, and things are starting to change. By training these models on scientific datasets, we’re seeing real progress. AI can now analyze drug targets, assess risks, and even suggest next steps for validation. It’s not perfect yet, but the groundwork is being laid for a future where drug discovery becomes faster, smarter, and more efficient. In this episode, we’ll dig into how AI is shaking up target discovery, why data is so critical to this evolution, and where this technology could take us next.
📣🎙️ TODAY’S POCAST:
( 0:32 ) Intro
( 1:27 ) AI’s Role in Target Discovery
( 2:42 ) AI in Alzheimer’s Research
( 4:21 ) AI in Drug Design
( 6:11 ) Fully Automated Drug Discovery
( 8:10 ) AI in Clinical Trials
( 9:48 ) Challenges: Data, Transparency, and Ethics
( 11:20 ) Unlocking Treatments and Preventing Disease
( 13:31 ) Faster, Better Healthcare
( 14:38 ) AI + Humans Shaping the Future
( 16:36 ) Embrace the Possibilities
CONCLUSION
We hope you are enjoying our first leap into the podcast world! Instead of waiting until everything is perfect, we’re diving in and will continue improving as we go. Feel free to send us your suggestions, feedback, or constructive criticism—we’d love to hear from you!
As a reminder, if looking to go deeper into the topics we cover check out our website BowTiedBiotech.com, or DM us on twitter, or email us: bowtiedbiotech@gmail.com
ABOUT BOWTIEDBIOTECH
As a reminder, the purpose of the BowTiedBiotech substack is two-fold. Primarily, we aim to provide our scientist audience the tools to build a biotech company and ultimately translate their ideas into medicines for patients. Secondarily, biotech investors may find this substack useful as we will be providing weekly market updates of the public AND private markets as well as heavily leveraging current financing events as teaching examples.
DISCLAIMER
None of this is to be deemed legal or financial advice of any kind. All updates are sourced from publicly available disclosures. Insights are *opinions* written by an anonymous cartoon/scientist/investor.
TOP BOWTIEDBIOTECH NEWSLETTERS
Share this post